CTRI/2016/09/007259
Completed
Phase 2
Pharmaceutical, analytical, preclinical and clinical study of Talapotaka churna in the management of type-2 Diabetes mellitus - TPC in DM II
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Type II Diabetes mellitus
- Sponsor
- Banaras Hindu University
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Blood Sugar Leval
- •Fasting \- \>126 mg/dl \- \<200 mg/dl
- •Postprandial \- \>200 mg/dl \- \<350 mg/dl
Exclusion Criteria
- •Diabetes mellitus Type I and Type II with serious complications like Nephropathy, CAD etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Finger millet cookies for Iron Deficiency AnaemiaHealth Condition 1: D509- Iron deficiency anemia, unspecifiedCTRI/2024/04/066035Banaras Hindu University
Not yet recruiting
Phase 2
Role of phalatrikadi ghana in Fatty LiverCTRI/2023/11/059886Institute of Medical Science Department of Rasa Shastra evum Bhaishajya Kalpana
Not yet recruiting
Phase 2
Effect of Brahmighrta in the management of DementiaHealth Condition 1: F192- Other psychoactive substance dependenceCTRI/2022/11/047302Banaras Hindu University
Not yet recruiting
Phase 2
Clinical Study of dadrudrawanal lepa and cream in the management of DADRU (Skin disease)Manas Klaibya (Psychological impotence) in Male Participants�CTRI/2022/09/045203ational Institute of Ayurveda Deemed to be University De novo
Active, not recruiting
Phase 2
Effect of kasaghna dhooma varti in Cough.Health Condition 1: J00- Acute nasopharyngitis [common cold]CTRI/2022/11/047243GOVERNMENT AYURVEDIC COLLEGE AND HOSPITA